Logo
    Search

    life sciences

    Explore "life sciences" with insightful episodes like "The Future Of The American Drinker", "Next Unicorns evaluation + Ask Jason | E1590", "Real Estate Trends: Residential & Commercial" and "E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries" from podcasts like ""Motley Fool Money", "This Week in Startups", "Motley Fool Money" and "This Week in Startups"" and more!

    Episodes (4)

    The Future Of The American Drinker

    The Future Of The American Drinker
    Beer continues to shine but will future generations be less likely to drink alcohol at all? (00:21) Bill Barker and Deidre Woollard discuss: - What’s driving the rapid growth of Modelo. - If wine and spirits can rebound for Constellation Brands. - The future of cannabis and Tilray’s tough path to profitability. (17:17)  Deidre Woollard interviews Joel Marcus, CEO of Alexandria Real Estate Equities about the future of this life sciences real estate investment trust. Companies discussed: ARE, STZ, TLRY Host: Deidre Woollard Guests: Bill Barker, Joel Marcus Producer: Ricky Mulvey Engineers: Dan Boyd, Heather Horton Learn more about your ad choices. Visit megaphone.fm/adchoices

    Next Unicorns evaluation + Ask Jason | E1590

    Next Unicorns evaluation + Ask Jason | E1590

    New format! Jason evaluates some prior Next Unicorns company's performances since the CEO appeared on the podcast (2:06), and contextualizes the fundraising market throughout the past three years. Then, Jason wraps the show by answering listener questions! (48:18)

    (0:00) Jason tees up today's new Next Unicorns format!

    (2:06) Jason shares some thoughts on why he started The Next Unicorns series and tees up some of the most successful companies over the first three seasons

    (5:32) E971: Checkr CEO Daniel Yanisse

    (10:37) E987: Upgrade CEO Renaud Laplanche

    (13:59) OpenPhone - Get an extra 20% off any plan for your first 6 months at https://openphone.com/twist 

    (15:29) E992: former Expanse CEO Tim Junio

    (23:14) LinkedIn Marketing -  Get a $100 LinkedIn ad credit at LinkedIn.com/nextunicorn

    (24:51) E998: Benchling CEO Saji Wickramasekara

    (28:32) E1089: Insitro CEO Daphe Koller

    (33:26) Kalshi - Sign up at https://kalshi.com/twist and receive $25 after trading your first 100 contracts

    (34:57) E1098: Cockroach Labs CEO Spencer Kimball

    (38:19) E1113: Loom CEO Joe Thomas

    (43:02) E1246: Divvy Homes CEO Adena Hefets

    (48:18) Ask Jason: 2023's "Why now?", Jason's favorite qualities in a founder and person, greatest acquisitions of all time

    FOLLOW Jason: https://linktr.ee/calacanis

    FOLLOW Molly: https://twitter.com/mollywood

    Subscribe to our YouTube to watch all full episodes:

    https://www.youtube.com/channel/UCkkhmBWfS7pILYIk0izkc3A?sub_confirmation=1

    Real Estate Trends: Residential & Commercial

    Real Estate Trends: Residential & Commercial
    We’ve got two CEO interviews and several real estate trends for investors to watch. (1:10) Deidre Woollard interviews Nick Bailey, President and CEO of RE/MAX, one of the largest residential real estate brokerages in the world. They discuss the long-term forces driving single-family home buying and what may cool the surge in multi-family properties. (18:25) Motley Fool contributor Marc Rappaport speaks with Joel Marcus, CEO and founder of Alexandria Real Estate Equities. They break down why life sciences buildings have proven to be a bright spot in commercial real estate and how Marcus’ company built long-term relationships with Eli Lilly and Merck. Stocks discussed: RMAX, ARE, LLY, MRK Hosts: Deidre Woollard, Marc Rappaport Guests: Nick Bailey, Joel Marcus Producer: Ricky Mulvey Engineers: Dan Boyd, Brandon Gentry Learn more about your ad choices. Visit megaphone.fm/adchoices

    E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries

    E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries
    0:53 Jason intros Sajith Wickramasekara
    1:40 What does Benchling do?
    2:24 How did Sajith get into life science?
    6:55 Benchling's value proposition for scientists
    9:04 How do they charge?
    10:43 Is Chamath Palihapitiya the most famous Sri Lankan in the US?
    13:25 Why immunotherapy is the most exciting development in life science
    19:00 3D Printing & harvesting organs in other species
    20:50 Ethics of editing a human embryo
    28:19 How did the scientific community respond to the embryo controversy
    29:52 Breakthroughs in gene therapy
    34:09 Defining the line between quackery & brilliance
    42:37 Upside & downside of genetically modified crops
    47:54 What is the best approach for breakthroughs in life science?